News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
A month has gone by since the last earnings report for Fastenal (FAST). Shares have added about 15.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Fastenal due for …
Sharemaestro market context Trend signal active 52 weeks +2.9%Zenas BioPharma (NASDAQ:ZBIO) experienced a 6.6% stock price drop after reporting disappointing quarterly earnings, with an EPS of $(1.77) against an estimated $(1.12) and revenue of $1 million against a $15 million forecast. Despite the earnings miss, analysts generally maintain a "Moderate Buy" rating …
Ciena (CIEN) stock rose 11% after securing a major DWDM network deal with e& UAE and successfully completing a quantum-safe networking trial with Quantum Corridor and Toshiba. These developments highlight Ciena's continued success in securing large service provider contracts and its forward-thinking approach to …
Businessman work with ai for economy analysis financial result by digital augmented reality graph by Natee K Jindakum via Shutterstock Ciena Corporation (CIEN), headquartered in Hanover, Maryland, is a network technology company that provides hardware, software, and services for various network operators. Valued at …
Sharemaestro market context Price below Trend Line 52 weeks +324.3% · Next-week setup negative 31.7%Renasant Corporation TUPELO, Miss., Aug. 13, 2026 (GLOBE NEWSWIRE) -- The board of directors of Renasant Corporation (NYSE: RNST) approved the payment of a quarterly cash dividend of twenty-four cents ($0.24) per share to be paid September 30, 2026, to shareholders of record as …
Zenas BioPharma, Inc. (ZBIO) reported its financial results for the quarter ended 2026, showing revenue of $1M and a net loss of ($111.46M), with a diluted loss per share of ($1.77). These figures represent a significant decrease in revenue and an increase in net …
This article is a brief financial announcement from Investing.com, stating that Zenas Biopharma Inc. filed a Form 8K on August 13th. The filing is related to the company's financial activities and includes the stock symbol ZBIO, which showed a -6.68% change. The content primarily …
ZenaTech has expanded its ZenaWorx drone-based construction monitoring software to include digital terrain modeling (DTM) capabilities, enabling precise measurement of cut-and-fill volumes, grading accuracy, and drainage for large-scale earthworks. The company announced its first paying customer for an AI data center construction project, targeting …
ZenaTech has acquired Galena-Benchmark Engineering, a civil engineering and land surveying firm based in Idaho. This acquisition marks ZenaTech's 27th Drone as a Service acquisition and expands its presence to its 13th U.S. state, allowing it to integrate its drone technology into an established …
Zenas BioPharma (ZBIO) announced a Q2 loss of $1.77 per share, which is significantly wider than FactSet's estimated loss of $1.12 per share. The company reported Q2 revenue of $1.0 million. Zenas BioPharma is a clinical-stage biopharmaceutical company focused on autoimmune diseases with lead …
Zenas BioPharma announced its second quarter 2026 financial results and provided a corporate update, highlighting the FDA's acceptance of the obexelimab BLA for IgG4-RD with a PDUFA date of May 27, 2027. The company also reported positive Phase 3 INDIGO trial results for obexelimab, …
Zenas BioPharma (ZBIO) reported a second-quarter 2026 net loss of $111.5 million on $1.0 million in revenue, an increase from a $52.2 million net loss in the prior-year quarter. The company ended the quarter with $673.9 million in cash and investments, and its biologics …
Sei Investments Co. has acquired 52,235 shares of Denali Therapeutics Inc. (NASDAQ:DNLI) valued at approximately $1.0 million, contributing to institutional investors' 92.92% ownership of the company. Despite reporting a quarterly loss of $0.68 per share, Denali's revenue exceeded expectations, and analysts maintain a "Moderate …
This article analyzes Tenable Holdings Inc. (NASDAQ: TENB) using AI models to generate trading strategies and multi-timeframe signal analysis. It highlights strong near and mid-term positive sentiment, potential upside, and provides specific long, breakout, and risk-hedging strategies with entry, target, and stop-loss levels. The …
Lionsgate Studios Corp. (NYSE:LION) has received a "Moderate Buy" consensus recommendation from analysts, with an average 12-month price target of $15.575, exceeding its current share price of $11.73. Recent analyst actions include downgrades to "neutral" by Citigroup and Zacks Research, while Barrington Research and …
Fastenal Company (NASDAQ:FAST) has received a consensus "Hold" rating from brokerages, with an average 12-month price target of $49.17. The company's recent quarterly earnings met expectations with $0.33 EPS and $2.39 billion in revenue, representing a 14.7% year-over-year increase. Fastenal also raised its quarterly …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Ciena has delivered very strong share price gains over the past few years, yet the valuation checks send mixed signals, with an intrinsic …
Sharemaestro market context Price below Trend Line 52 weeks +324.3% · Next-week setup negative 31.7%Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Ciena (NYSE:CIEN) has been selected by e& UAE to supply technology for a next generation, high capacity DWDM network build in the country. The …
Sharemaestro market context Price below Trend Line 52 weeks +324.3% · Next-week setup negative 31.7%Levi & Korsinsky, LLP has announced an investigation into Tenax Therapeutics (TENX) after the company's stock value dropped significantly following the failure of its Phase 3 LEVEL trial for TNX-103. Shareholders who lost money are encouraged to submit their information as the firm investigates …
Renaissancere Holdings Ltd. (NYSE: RNR) shows weak near-term sentiment but long-term strength, with a mid-channel oscillation pattern in play. AI models have generated distinct trading strategies including a short setup targeting a 5.5% downside with a 0.3% risk. The analysis highlights divergent sentiment across …
Ciena Corp (CIEN) saw a significant stock price increase of 12.38% on August 12, driven by new network contracts, rising demand for AI infrastructure, and positive macroeconomic sentiment due to cooling inflation. Analysts have issued Buy ratings with an average price target of $588.59, …
This Simply Wall St analysis provides a detailed overview of Enanta Pharmaceuticals (ENTA), a biotechnology company specializing in small molecule drugs. The report covers the company's valuation, future growth prospects (revenue forecast to grow 21.99% annually), past performance, financial health, and dividend policy, noting …
Shenandoah Telecommunications Company (Shentel) announced the successful completion of its 2026 Shentel Cares Summer Backpack Program and Shentel Caring Days, which raised over $28,000 for local organizations combating food insecurity. Employees also contributed 330 volunteer hours to hunger relief and other essential services. This …
Tenable Holdings (NASDAQ:TENB) recently reported strong earnings, which were well-received by the market. The company exhibits a strong ability to convert reported profits into free cash flow, evidenced by a negative accrual ratio of -0.86, indicating its free cash flow significantly exceeds reported profit. …
Fastenal (FAST) recently reported quarterly results with revenue exceeding forecasts and earnings matching expectations, yet analysts largely maintain a cautious "Hold" rating. This dichotomy raises questions about the effectiveness of Fastenal's digital strategy amidst mixed industrial demand, cost pressures, and e-commerce competition. The article …
This article from Stock Traders Daily provides a detailed AI-driven analysis of Prothena Corporation Plc (PRTA), highlighting strong near-term sentiment but a neutral mid and long-term outlook. It outlines specific institutional trading strategies (Long, Momentum Breakout, and Risk Hedging) with entry/target/stop-loss zones, and presents …
Zacks Research has downgraded Tenaris (NYSE:TS) from a "strong-buy" to a "hold" rating, aligning with the overall analyst consensus. Despite the downgrade, Tenaris exceeded its quarterly earnings expectations, reporting $0.95 EPS against an estimated $0.79, though revenue saw a slight year-over-year decline. The company's …
Zacks Research has increased its Q3 2026 EPS estimate for RenaissanceRe (NYSE: RNR) to $5.93 from $4.77, with a full-year 2026 forecast of $41.20, although the consensus estimate is slightly higher at $41.94. The company's stock opened at $316.47, near its 52-week high, following …
Search by ticker symbol or company name and select a result to open its chart.